Alex Zhavoronkov
@elonverse.bsky.social
My only objective function is to extend productive longevity for everyone on the planet. Here to share research papers. https://x.com/biogerontology
Reposted by Alex Zhavoronkov
Thanks to @sebastian.bsky.social for the great interview for the @newquantumera.com We talked about #GQE and #VQE and #QML #quantummachinelearning #quantum #compchemsky
New episode posted! Great conversation with @aspuru.bsky.social about his generative quantum eigensolver technique! share.transistor.fm/s/a9258b99
Generative Quantum Eigensolver with Alán Aspuru-Guzik | The New Quantum Era | Episode 42
share.transistor.fm
January 21, 2025 at 2:20 AM
Thanks to @sebastian.bsky.social for the great interview for the @newquantumera.com We talked about #GQE and #VQE and #QML #quantummachinelearning #quantum #compchemsky
Reposted by Alex Zhavoronkov
Excited to share our latest work, published this morning in Nature Biotechnology! 🎉 We developed a hybrid quantum computing-enhanced generative model to design KRAS inhibitors. Check it out here: rdcu.be/d68Fs.
Some fascinating insights along the way:
Some fascinating insights along the way:
January 22, 2025 at 8:17 PM
Excited to share our latest work, published this morning in Nature Biotechnology! 🎉 We developed a hybrid quantum computing-enhanced generative model to design KRAS inhibitors. Check it out here: rdcu.be/d68Fs.
Some fascinating insights along the way:
Some fascinating insights along the way:
Reposted by Alex Zhavoronkov
Part 1: Exciting news! Our research on quantum drug discovery is now in Nature Biotechnology. A Quantum Computer helped design KRAS inhibitors, an elusive cancer target. These inhibitors were successfully synthesized and tested, marking a milestone in healthcare innovation. 🚀
#QuantumComputing #KRAS
#QuantumComputing #KRAS
January 22, 2025 at 7:59 PM
Part 1: Exciting news! Our research on quantum drug discovery is now in Nature Biotechnology. A Quantum Computer helped design KRAS inhibitors, an elusive cancer target. These inhibitors were successfully synthesized and tested, marking a milestone in healthcare innovation. 🚀
#QuantumComputing #KRAS
#QuantumComputing #KRAS
Reposted by Alex Zhavoronkov
Glad to see our research on thr first #quantum + #ai application with experimental confirmation for #drugdiscovery out in Nature Biotechnology!
@ghazivakili.bsky.social @elonverse.bsky.social Igor Stagljar @thematterlab.bsky.social
@ghazivakili.bsky.social @elonverse.bsky.social Igor Stagljar @thematterlab.bsky.social
While we often hear of potential long-range synergy between #AI (which requires enormous computing power) + #quantumcomputing, today we have first-of-its-kind research from #UofT + Insilico Medicine that demonstrates it firsthand. Follow the link to learn more or read on below.
U of T researchers develop new approach using quantum computers to accelerate drug discovery
A study co-led by University of Toronto researchers and Insilico Medicine has demonstrated for the first time the potential of quantum computing and artificial intelligence to transform the drug disco...
temertymedicine.utoronto.ca
January 22, 2025 at 9:12 PM
Glad to see our research on thr first #quantum + #ai application with experimental confirmation for #drugdiscovery out in Nature Biotechnology!
@ghazivakili.bsky.social @elonverse.bsky.social Igor Stagljar @thematterlab.bsky.social
@ghazivakili.bsky.social @elonverse.bsky.social Igor Stagljar @thematterlab.bsky.social
Another day, another paper -- and this research paper paves the way to a therapeutic program with very real therapeutic opportunity. Welcome our new paper with CUHK titled "Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis"
January 17, 2025 at 9:48 PM
Another day, another paper -- and this research paper paves the way to a therapeutic program with very real therapeutic opportunity. Welcome our new paper with CUHK titled "Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis"
And now, many of my friends with PRMT5 inhibitors in their pipelines will take notice. Welcome the new paper from University of Chicago Evgeny Izumchenko's group showing that PRMT5is can serve as powerful agents in adenoid cystic carcinoma of salivary glands.
January 17, 2025 at 4:01 AM
And now, many of my friends with PRMT5 inhibitors in their pipelines will take notice. Welcome the new paper from University of Chicago Evgeny Izumchenko's group showing that PRMT5is can serve as powerful agents in adenoid cystic carcinoma of salivary glands.
Huge congratulations to Dominika Wilczok on her first single author paper on generative AI for aging research. This paper has over 170 references and is a gargantuan amount of work.
www.aging-us.com/article/2061...
www.aging-us.com/article/2061...
January 17, 2025 at 3:45 AM
Huge congratulations to Dominika Wilczok on her first single author paper on generative AI for aging research. This paper has over 170 references and is a gargantuan amount of work.
www.aging-us.com/article/2061...
www.aging-us.com/article/2061...
Reposted by Alex Zhavoronkov
Inside the great AI drug race: www.bbc.com/news/article...
How AI uncovers new ways to tackle difficult diseases
Pharmaceutical firms are turning to AI to find new molecules that might be able to tackle disease.
www.bbc.com
January 10, 2025 at 4:04 PM
Inside the great AI drug race: www.bbc.com/news/article...
If you don't have quantitative benchmarks, you can not improve. Check out Domika Wilczok's paper on challenges in AI pharma R&D
ascpt.onlinelibrary.wiley.com/doi/full/10....
ascpt.onlinelibrary.wiley.com/doi/full/10....
Progress, Pitfalls, and Impact of AI‐Driven Clinical Trials
Since the deep learning revolution of the early 2010s, significant efforts and billions of dollars have been invested in applying artificial intelligence (AI) to drug discovery and development (AIDD)....
ascpt.onlinelibrary.wiley.com
January 5, 2025 at 9:18 AM
If you don't have quantitative benchmarks, you can not improve. Check out Domika Wilczok's paper on challenges in AI pharma R&D
ascpt.onlinelibrary.wiley.com/doi/full/10....
ascpt.onlinelibrary.wiley.com/doi/full/10....
Don't forget to read about the best device to measure your skin over time in the context of your daily life.
Thousands of meta clinical trials worldwide now.
onlinelibrary.wiley.com/doi/10.1111/...
Thousands of meta clinical trials worldwide now.
onlinelibrary.wiley.com/doi/10.1111/...
Skinly: A novel handheld IoT device for validating biophysical skin characteristics
Background
Recent advancements in artificial intelligence have revolutionized dermatological diagnostics. These technologies, particularly machine learning (ML), including deep learning (DL), have s.....
onlinelibrary.wiley.com
January 5, 2025 at 7:55 AM
Don't forget to read about the best device to measure your skin over time in the context of your daily life.
Thousands of meta clinical trials worldwide now.
onlinelibrary.wiley.com/doi/10.1111/...
Thousands of meta clinical trials worldwide now.
onlinelibrary.wiley.com/doi/10.1111/...
I noticed that @natureportfolio.bsky.social started tracking BlueSky in @altmetric.com @altmetric.bsky.social , so I decided to join.
Check out our latest paper in @naturebiotech.bsky.social
www.nature.com/articles/s41...
Check out our latest paper in @naturebiotech.bsky.social
www.nature.com/articles/s41...
Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor - Nature Biotechnology
Generative artificial intelligence is used to design an effective treatment for inflammatory bowel disease in preclinical models.
www.nature.com
December 15, 2024 at 5:33 AM
I noticed that @natureportfolio.bsky.social started tracking BlueSky in @altmetric.com @altmetric.bsky.social , so I decided to join.
Check out our latest paper in @naturebiotech.bsky.social
www.nature.com/articles/s41...
Check out our latest paper in @naturebiotech.bsky.social
www.nature.com/articles/s41...
1/ 🚨 Breakthrough in IBD treatment! Insilico Medicine's AI-developed gut-restricted PHD inhibitor, ISM012-042, offers a novel solution for intestinal inflammation and mucosal barrier repair. 🚀 Read on for key findings from the latest @NatureBiotech study. 🧵
December 15, 2024 at 5:31 AM
1/ 🚨 Breakthrough in IBD treatment! Insilico Medicine's AI-developed gut-restricted PHD inhibitor, ISM012-042, offers a novel solution for intestinal inflammation and mucosal barrier repair. 🚀 Read on for key findings from the latest @NatureBiotech study. 🧵
The 12th ARDD will transpire 25-29th of August, 2025 - mark your calendars for the largest aging research biotechnology conference on the planet!
December 15, 2024 at 5:29 AM
The 12th ARDD will transpire 25-29th of August, 2025 - mark your calendars for the largest aging research biotechnology conference on the planet!